Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH +1.57%43 Return-on-Tangible-Asset is 12.55% as of Mar. 2026, which is 0% above its 10-year median of 12.51. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 679 Healthcare Providers & Services companies, GPT Healthcare ranks better than 79.38% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. GPT Healthcare's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹583 Mil. GPT Healthcare's average total tangible assets for the quarter that ended in Mar. 2026 was ₹4,643 Mil. Therefore, GPT Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 12.55%.
The historical rank and industry rank for GPT Healthcare's Return-on-Tangible-Asset or its related term are showing as below:
NSE:GPTHEALTH'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.65 Med: 12.51 Max: 14.24
Current: 9.67
During the past 6 years, GPT Healthcare's highest Return-on-Tangible-Asset was 14.24%. The lowest was 6.65%. And the median was 12.51%.
NSE:GPTHEALTH's Return-on-Tangible-Asset is ranked better than 79.38% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs NSE:GPTHEALTH: 9.67
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
GPT Healthcare Return-on-Tangible-Asset Related Terms
GPT Healthcare Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for GPT Healthcare's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GPTHEALTH vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 12.55% mean?
GPT Healthcare (NSE:GPTHEALTH) has a Return-on-Tangible-Asset of 12.55% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on GPT Healthcare and its competitors. This is near median its historical median of 12.51. Over the past decade, GPT Healthcare's Return-on-Tangible-Asset has ranged from 6.65 to 14.24. According to the industry distribution chart, GPT Healthcare ranks #140 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is GPT Healthcare's Return-on-Tangible-Asset too high?
GPT Healthcare's current Return-on-Tangible-Asset of 12.55% is near median its 10-year median of 12.51. Over the past 10 years, this metric has ranged from a low of 6.65 to a high of 14.24. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.59. GPT Healthcare's value of 12.55% is 384.6% above this industry median. Based on the distribution chart, GPT Healthcare ranks #140 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GPT Healthcare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #140 out of 679 companies for Return-on-Tangible-Asset. This places GPT Healthcare in the top 21% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.59. GPT Healthcare's value of 12.55% is 384.6% above this benchmark. Historically, GPT Healthcare's own Return-on-Tangible-Asset has ranged from 6.65 to 14.24 over the past decade. While the company's 10-year median is 12.51 vs. the industry median of 2.59, GPT Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.59, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current Return-on-Tangible-Asset of 12.55% is 384.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current Return-on-Tangible-Asset is 12.55%, which is near median its own 10-year median of 12.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current Return-on-Tangible-Asset of 12.55%. The current Return-on-Tangible-Asset is 12.55%, which is near median its 10-year median of 12.51 and 384.6% above the Healthcare Providers & Services industry median of 2.59. GPT Healthcare's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current Return-on-Tangible-Asset is 12.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
43GF Score
Get the complete analysis for NSE:GPTHEALTH
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
